Final Overall Survival Analysis of the TOURMALINE-MM1 Phase III Trial of Ixazomib, Lenalidomide, and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma.

Details

Language :

English

ISSN :

0732183X

Volume :

39

Issue :

22

Database :

Supplemental Index

Journal :

Journal of Clinical Oncology

Publication Type :

Academic Journal

Accession number :

153394044

Full Text :

https://doi.org/10.1200/JCO.21.00972